Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2022
Source ID
10.1165/rcmb.2021-0156oc

Entities

People

  • Bedia Akosman
  • Chang-min Lee
  • Chun Geun Lee
  • Erica L Herzog
  • Jack A. Elias
  • Jae-Hyun Lee
  • Jin Wook Park
  • Joyce H. Lee
  • Mun-ock Kim
  • Suchitra Kamle
  • Xue Yan Peng

Organizations

  • Brown University
  • Korea Research Institute of Bioscience and Biotechnology
  • National Heart, Lung, and Blood Institute
  • National Institute of General Medical Sciences
  • United States Department of Defense
  • Yale School of Medicine
  • Yonsei University